In the present study, we found that the current use of HRT increased the RR of being diagnosed with both favourable as well as nonfavourable breast cancer types, except for hormone receptor status, where we found significantly higher RR of hormone receptor-positive breast cancer compared to hormone receptor-negative breast cancer among current users of HRT. The gene discussed is NR4A1; the disease is breast carcinoma.